The US Food and Drug Administration (FDA) has approved a new drug named Pomalyst (pomalidomide) for patients who received and did not respond to prior cancer therapies. Pomalyst, the third drug in a class of immunomodulatory agents ...
UK-based pharmaceutical company Bristol-Myers Squibb and AstraZeneca have announced that the National Institute for Health and Clinical Excellence (NICE) in the UK has issued an Appraisal Consultation Document (ACD) for its first-in-class, ...
Tags: pharmaceutical company, Bristol-Myers Squibb, AstraZeneca, NICE
Merck has received FDA approval for an over-the-counter (OTC) treatment for overactive bladder (OAB) in women, Oxytrol for women. Various studies demonstrated a woman's ability to recognize OAB symptoms, understand vital safety ...
Tags: bladder OTC treatment, Merck, OAB symptoms
The US Food and Drug Administration (FDA) has approved L300 neurostimulation system, designed for treating children suffering from foot drop. The neuromuscular stimulation device, which also helps in treating children suffering from ...
Tags: FDA, L300 neurostimulation system, children, foot drop
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis Ilaris for use in acute gouty arthritis patients who are not suitable for current treatments. The only ...
Tags: Medicinal Products, therapies, treatments
InterMune Canada has announced the availability of idiopathic pulmonary fibrosis (IPF) therapy, Esbriet, in Canada. University of Toronto professor and vice-chair of medicine and University Health Network IPF researcher and consultant ...
Tags: fibrosis therapy, InterMune, medicine
Cancer patients in the north-east of England will be able to receive modern radiosurgery treatments without having to travel outside the region since the Northern Centre for Cancer Care (NCCC) in Newcastle –upon-Tyne announced that it ...
Tags: Cancer patients, NCCC, TrueBeam STx, medical linear accelerators
Pfizer has announced the availability of attention deficit hyperactivity disorder (ADHD) therapy, Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension, in the US. The extended-release liquid ...
Tags: Pfizer, ADHD therapy, Quillivant XR CII
ElectroCore has initiated enrolling patients in a clinical trial of its GammaCore nVNS therapy, designed for preventing chronic migraine. The easy-to-use, non-invasive device, which enables self-administration of therapy, stimulates ...
Bristol-Myers Squibb and Pfizer have announced the US FDA's approval for Eliquis (apixaban), used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In 2007, Pfizer and Bristol-Myers ...
Tags: US, FDA, Eliquis, patients, nonvalvular atrial fibrillation
Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...
Tags: Japan, approval, anticoagulant, subanalysis
AMAG Pharmaceuticals has submitted a supplemental new drug application (sNDA) for intravenous (IV) use of Feraheme injection, to FDA. The company is seeking approval for the label expansion of Feraheme to include all iron deficiency ...
Tags: Feraheme Injection, AMAG, SNDA
University Medical Center Groningen (UMCG) has treated the first patient using its RePneu lung volume reduction coil (LVRC), designed for relieving breathing difficulty in patients with severe emphysema, in RENEW pivotal trial. The ...
St Jude Medical has received CE mark approval for its Portico Transcatheter aortic heart valve which is designed to treat patients with severe aortic stenosis who are at intermediate risk for undergoing open-heart surgery. The 23 mm ...
Tags: CE mark, aortic heart valve, medical device, Medical equipment
The AtriCure has obtained the US Food and Drug Administration (FDA) clearance to commence three-year Ablate post approval study (PAS), designed for the surgical correction of atrial fibrillation. The 350 patient study is designed to ...
Tags: AtriCure, FDA clearance, post approval study, PAS, Synergy ablation system